Prediction:
share price will settle at around $1.60 in August, and drift down to below $1.40 by October
no partnership will be announced in 2017
there will be further capital raising in 2017 (share issue)
no meaningful or new trial data will be released in 2017
Not good for those that haven't sold yet . . . . . . not selling basically means that you believe SI has a developed a single treatment which works for each of heart failure and RA and GVDH and Crohn's and Diabetes . . . . . .and . . . . and. . . . . . and big Pharma and other investors are all blind to it . . . . doesn't seem overly likely to me! Doesn't mean that the share price isn't going to rally again and I think that a smart trader (not me, I got very lucky) can definitely make money on this stock, but long term holders? Not so sure . . . .
MSB Price at posting:
$1.70 Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)